Literature DB >> 25995384

ZBTB7A Suppresses Melanoma Metastasis by Transcriptionally Repressing MCAM.

Xue-Song Liu1, Matthew D Genet1, Jenna E Haines1, Elie K Mehanna1, Shaowei Wu2, Hung-I Harry Chen3, Yidong Chen3, Abrar A Qureshi4, Jiali Han2, Xiang Chen5, David E Fisher6, Pier Paolo Pandolfi7, Zhi-Min Yuan8.   

Abstract

UNLABELLED: The excessive metastatic propensity of melanoma makes it the most deadly form of skin cancer, yet the underlying mechanism of metastasis remains elusive. Here, mining of cancer genome datasets discovered a frequent loss of chromosome 19p13.3 and associated downregulation of the zinc finger transcription factor ZBTB7A in metastatic melanoma. Functional assessment of ZBTB7A-regulated genes identified MCAM, which encodes an adhesion protein key to melanoma metastasis. Using an integrated approach, it is demonstrated that ZBTB7A directly binds to the promoter and transcriptionally represses the expression of MCAM, establishing ZBTB7A as a bona fide transcriptional repressor of MCAM. Consistently, downregulation of ZBTB7A results in marked upregulation of MCAM and enhanced melanoma cell invasion and metastasis. An inverse correlation of ZBTB7A and MCAM expression in association with melanoma metastasis is further validated with data from analysis of human melanoma specimens. IMPLICATIONS: Together, these results uncover a previously unrecognized role of ZBTB7A in negative regulation of melanoma metastasis and have important clinical implications. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25995384      PMCID: PMC4543565          DOI: 10.1158/1541-7786.MCR-15-0169

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  30 in total

1.  Expression of MCAM/MUC18 by human melanoma cells leads to increased tumor growth and metastasis.

Authors:  S Xie; M Luca; S Huang; M Gutman; R Reich; J P Johnson; M Bar-Eli
Journal:  Cancer Res       Date:  1997-06-01       Impact factor: 12.701

2.  Purification and characterization of FBI-1, a cellular factor that binds to the human immunodeficiency virus type 1 inducer of short transcripts.

Authors:  F Pessler; P S Pendergrast; N Hernandez
Journal:  Mol Cell Biol       Date:  1997-07       Impact factor: 4.272

Review 3.  POZ for effect--POZ-ZF transcription factors in cancer and development.

Authors:  Kevin F Kelly; Juliet M Daniel
Journal:  Trends Cell Biol       Date:  2006-09-22       Impact factor: 20.808

4.  Role of the proto-oncogene Pokemon in cellular transformation and ARF repression.

Authors:  Takahiro Maeda; Robin M Hobbs; Taha Merghoub; Ilhem Guernah; Arthur Zelent; Carlos Cordon-Cardo; Julie Teruya-Feldstein; Pier Paolo Pandolfi
Journal:  Nature       Date:  2005-01-20       Impact factor: 49.962

Review 5.  Bioimmunotherapy for melanoma using fully human antibodies targeting MCAM/MUC18 and IL-8.

Authors:  Vladislava O Melnikova; Menashe Bar-Eli
Journal:  Pigment Cell Res       Date:  2006-10

6.  Novel genes associated with malignant melanoma but not benign melanocytic lesions.

Authors:  Dmitri Talantov; Abhijit Mazumder; Jack X Yu; Thomas Briggs; Yuqiu Jiang; John Backus; David Atkins; Yixin Wang
Journal:  Clin Cancer Res       Date:  2005-10-15       Impact factor: 12.531

7.  Osteoclast-derived zinc finger (OCZF) protein with POZ domain, a possible transcriptional repressor, is involved in osteoclastogenesis.

Authors:  A Kukita; T Kukita; M Ouchida; H Maeda; H Yatsuki; O Kohashi
Journal:  Blood       Date:  1999-09-15       Impact factor: 22.113

8.  Development of a tissue array for primary melanoma with long-term follow-up: discovering melanoma cell adhesion molecule as an important prognostic marker.

Authors:  Marc D Pacifico; Rajiv Grover; Paul I Richman; Frances M Daley; Francesca Buffa; George D Wilson
Journal:  Plast Reconstr Surg       Date:  2005-02       Impact factor: 4.730

9.  Leukemia/lymphoma-related factor, a POZ domain-containing transcriptional repressor, interacts with histone deacetylase-1 and inhibits cartilage oligomeric matrix protein gene expression and chondrogenesis.

Authors:  Chuan-ju Liu; Lisa Prazak; Marc Fajardo; Shuang Yu; Neetu Tyagi; Paul E Di Cesare
Journal:  J Biol Chem       Date:  2004-08-26       Impact factor: 5.157

10.  MUC18, a melanoma-progression associated molecule, and its potential role in tumor vascularization and hematogenous spread.

Authors:  C Sers; G Riethmüller; J P Johnson
Journal:  Cancer Res       Date:  1994-11-01       Impact factor: 12.701

View more
  16 in total

1.  Circular RNA Circ_0016760 Modulates Non-Small-Cell Lung Cancer Growth Through the miR-577/ZBTB7A Axis.

Authors:  Yanhong Hao; Junfeng Xi; Yancai Peng; Burong Bian; Guangjun Hao; Yunfeng Xi; Zhibin Zhang
Journal:  Cancer Manag Res       Date:  2020-07-08       Impact factor: 3.989

Review 2.  Role of ZBTB7A zinc finger in tumorigenesis and metastasis.

Authors:  Atul Kumar Singh; Shiv Verma; Prem Prakash Kushwaha; Kumari Sunita Prajapati; Mohd Shuaib; Shashank Kumar; Sanjay Gupta
Journal:  Mol Biol Rep       Date:  2021-05-20       Impact factor: 2.316

3.  De novo ZBTB7A variant in a patient with macrocephaly, intellectual disability, and sleep apnea: implications for the phenotypic development in 19p13.3 microdeletions.

Authors:  Akira Ohishi; Yohei Masunaga; Shigeo Iijima; Kaori Yamoto; Fumiko Kato; Maki Fukami; Hirotomo Saitsu; Tsutomu Ogata
Journal:  J Hum Genet       Date:  2019-10-23       Impact factor: 3.755

4.  Negative feedback loop between ZBTB7A and TGF-β in breast cancer.

Authors:  Yingying Shen; Renxian Cao; Wen Liu; Yuqing Zhou; Ying Wu; Jingjing Tan; Min Jin; Jing Zhong; Qinghai Zhang; Jianghua Liu; Xuyu Zu
Journal:  Oncol Lett       Date:  2017-06-01       Impact factor: 2.967

5.  Differences in Zbtb7a expression cause heterogeneous changes in human nasopharyngeal carcinoma CNE3 sublines.

Authors:  Fei Liu; Jiao Lan; Wei Jiao; Xianglan Mo; Yongta Huang; Huilan Ye; Ruiping Xiao; Yongli Wang; Mingzheng Mo; Liwei Shi
Journal:  Oncol Lett       Date:  2017-07-08       Impact factor: 2.967

6.  RegulatorTrail: a web service for the identification of key transcriptional regulators.

Authors:  Tim Kehl; Lara Schneider; Florian Schmidt; Daniel Stöckel; Nico Gerstner; Christina Backes; Eckart Meese; Andreas Keller; Marcel H Schulz; Hans-Peter Lenhof
Journal:  Nucleic Acids Res       Date:  2017-07-03       Impact factor: 16.971

7.  The histone demethylase KDM3A, and its downstream target MCAM, promote Ewing Sarcoma cell migration and metastasis.

Authors:  M Sechler; J K Parrish; D K Birks; P Jedlicka
Journal:  Oncogene       Date:  2017-03-20       Impact factor: 9.867

8.  ZBTB7A Enhances Osteosarcoma Chemoresistance by Transcriptionally Repressing lncRNALINC00473-IL24 Activity.

Authors:  Lu Zhang; Yuan Wang; Xiaojie Li; Xin Xia; Na Li; Ruiping He; Hongtao He; Chuanchun Han; Wenzhi Zhao
Journal:  Neoplasia       Date:  2017-09-21       Impact factor: 5.715

9.  Obesity-Induced Upregulation of ZBTB7A Promotes Lipid Accumulation through SREBP1.

Authors:  Jing-Ping Zhou; Yan-Dan Ren; Qin-Yu Xu; Yang Song; Fei Zhou; Mei-Ya Chen; Jing-Jing Liu; Li-Gang Chen; Jin-Shui Pan
Journal:  Biomed Res Int       Date:  2020-01-07       Impact factor: 3.411

10.  The miR-372-ZBTB7A Oncogenic Axis Suppresses TRAIL-R2 Associated Drug Sensitivity in Oral Carcinoma.

Authors:  Li-Yin Yeh; Cheng-Chieh Yang; Hsiao-Li Wu; Shou-Yen Kao; Chung-Ji Liu; Yi-Fen Chen; Shu-Chun Lin; Kuo-Wei Chang
Journal:  Front Oncol       Date:  2020-01-31       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.